Biotechnology News

MALVERN, Pa., Oct. 27, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...

MENLO PARK, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be...

AN4035 late-breaking abstract selected for an oral presentation at the upcoming ENA Symposium in Barcelona Oral presentation will include translational and EGFR combination data for first-in-class...

SAN DIEGO, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company targeting RAS-mutated cancer by leveraging PLK1 inhibition, today announced...

Arcutis today announced that management will present at the Guggenheim investor conference, taking place November 9-11, 2026, in Boston.

COMMUNIQUÉ DU 27 OCTOBRE 2026 RELATIF AU DÉPÔT DU PROJET DE NOTE D’INFORMATION ÉTABLI PAR LA SOCIÉTÉ EUROBIO SCIENTIFIC EN RÉPONSE AU PROJET D’OFFRE PUBLIQUE DE RETRAIT SUIVIE D’UN RETRAIT...

COMMUNIQUÉ DU 27 OCTOBRE 2026 RELATIF AU DÉPÔT D’UNE OFFRE PUBLIQUE DE RETRAIT SUIVIE D’UN RETRAIT OBLIGATOIREVISANT LES ACTIONS DE LA SOCIÉTÉ EUROBIO SCIENTIFIC Pièce jointe ...

– Results demonstrate consistent improvements across measures of disease activity, quality of life, and pharmacodynamic markers, with a tolerable safety profile across all afimetoran dose groups – –...

Addition continues to progress a novel pipeline of non-viral, LNP-delivered, RNA-only gene-addition therapies for severe, lifelong genetic and non-genetic diseasesCompany to present an oral...

Bavarian Nordic donates 75,000 doses of MVA-BN® and will also supply 150,000 doses to new global mpox vaccine emergency stockpile.